All the above data confirm the clinical significance of high liver stiffness and the molecules for higher stiffness-induced EMT (integrin β1, Snail, eIF4E, TGFβ1, and S100A11) in HCC progression and unfavorable outcome. The gene discussed is S100A11; the disease is hepatocellular carcinoma.